Literature DB >> 32368879

Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy.

Çiğdem Soydal1, Pınar Akkuş1, Mine Araz1, Güngör Utkan2.   

Abstract

Brachial plexopathy is a significant cause of pain and disability in patients with breast cancer. Major causes of brachial plexopathy in patients with breast cancer are metastatic invasion or radiation damage to the plexus. Differentiation between the two pathologies is important for appropriate treatment planning. The complicated anatomy of the plexus makes this a difficult area to image accurately. Magnetic resonance imaging (MRI) is the imaging modality of choice for diagnostic evaluation of these cases. We presented a case to demonstrate the role of 18F-flourodeoxyglucose positron emission tomography/computerized tomography for confirming metastatic brachial plexopathy when MRI findings were suspicious and for differentiating radiation-induced brachial plexopathy from metastatic plexopathy.

Entities:  

Keywords:  18F-fluorodeoxyglucose positron emission tomography; Brachial plexopathy; metastatic breast cancer

Year:  2020        PMID: 32368879      PMCID: PMC7201434          DOI: 10.4274/mirt.galenos.2019.40469

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther        ISSN: 2146-1414


  4 in total

1.  Brachial plexopathy in breast carcinoma--an unsolved problem.

Authors:  J J Wood; J Gawler; R J Whittle; M D Staunton
Journal:  Eur J Surg Oncol       Date:  1991-06       Impact factor: 4.424

2.  Metastatic Brachial Plexopathy in a Case of Recurrent Breast Carcinoma Demonstrated on (18)F-FDG PET/CT.

Authors:  Madhavi Tripathi; Chandan J Das; Anurag Srivastava; ChandraSekhar Bal; Arun Malhotra
Journal:  Nucl Med Mol Imaging       Date:  2013-10-09

3.  Magnetic resonance imaging in brachial plexopathy of cancer.

Authors:  D Thyagarajan; T Cascino; G Harms
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

4.  Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients.

Authors:  A Ahmad; S Barrington; M Maisey; R D Rubens
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.